Compliances- Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Evoq Remedies Ltd has submitted a compliance certificate to BSE for the quarter ended 31st March 2026, as required under SEBI's Depository Regulations. The certificate was issued by the company's Registrar and Share Transfer Agent (RTA), Accurate Securities & Registry Private Limited. The RTA confirms that all securities received from depository participants for dematerialization during the January–March 2026 quarter were processed within the SEBI-mandated timeline. The certificate also confirms that physical certificates received for demat were mutilated/cancelled after verification and the depository name was substituted as registered owner within the stipulated period. No details on the actual number of shares processed or any rejection figures are disclosed.
This is a routine quarterly regulatory compliance filing with no material business or financial information. It has no direct impact on the stock price or shareholder value, though it confirms the company remains compliant with SEBI depository processing timelines.